miacalcic injection 50 iuml
zuellig pharma pte. ltd. - salmon-calcitonin synthetic - injection - 50 iu/ml - salmon-calcitonin synthetic 50 iu/ml
burinex tablet 1 mg
zuellig pharma pte. ltd. - bumetanide - tablet - 1 mg - bumetanide 1 mg
kanarb tablet 120mg
zuellig pharma pte. ltd. - fimasartan potassium trihydrate 132.02mg eqv fimasartan potassium - tablet - fimasartan potassium trihydrate 132.02mg eqv fimasartan potassium 120 mg
kanarb tablet 60mg
zuellig pharma pte. ltd. - fimasartan potassium trihydrate 66.01mg eqv fimasartan potassium - tablet - fimasartan potassium trihydrate 66.01mg eqv fimasartan potassium 60mg
actonel once-a-week tablet 35 mg
zuellig pharma pte. ltd. - risedronate sodium - tablet, film coated - 35 mg - risedronate sodium 35 mg
one-alpha injection 2 mcgml
zuellig pharma pte. ltd. - alfacalcidol - injection - 2 mcg/ml - alfacalcidol 2 mcg/ml
brinavess concentrate for solution for infusion 20mg/ml
zuellig pharma pte. ltd. - vernakalant 18.1mg/ml equivalent vernakalant hydrochloride - infusion, solution concentrate - 20mg/ml
abevmy™ concentrate for solution for infusion 25mgml
zuellig pharma pte. ltd. - bevacizumab - injection, solution, concentrate - bevacizumab 25 mg/ml
fobancort cream
zuellig pharma pte. ltd. - betamethasone dipropionate 0.064% w/w eqv betamethasone; fusidic acid - cream - 0.064 w/w - betamethasone dipropionate 0.064% w/w eqv betamethasone 0.05% w/w; fusidic acid 2% w/w
fobancort ointment
zuellig pharma pte. ltd. - betamethasone dipropionate; sodium fusidate - ointment - 0.064% w/w - betamethasone dipropionate 0.064% w/w; sodium fusidate 2% w/w